Gasalia
- Manufacturer
- Laboratoires Boiron | Boiron Inc. | Boiron
- Effective date
- 2023-05-10
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 8
- Source
- full-release
- Hydrated at
- 2026-06-01 02:21:09
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredients** (in each tablet)
Carbo vegetabilis 6C HPUS (0.63 mg)
Lycopodium clavatum 6C HPUS (0.63 mg)
Nux moschata 6C HPUS (0.63 mg)
Raphanus sativus 6C HPUS (0.6 mg)
The letters “HPUS” indicate that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States.
OTC - PURPOSE SECTION
Purpose*
Carbo vegetabilis 6C HPUS ...Relieves stomach bloating with gas
Lycopodium clavatum 6C HPUS ... Relieves bloated lower abdomen
Nux moschata 6C HPUS... Relieves abdominal bloating accompanied by constipation
Raphanus sativus 6C HPUS... Relieves abdominal pain and bloating with difficulty passing gas
INDICATIONS & USAGE SECTION
Uses*
temporarily relieves bloating, pressure, discomfort, and pain commonly referred to as gas
OTC - STOP USE SECTION
Stop use and ask a doctor if symptoms persist continuously for more than 7 days or worsen.
OTC - WHEN USING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case of accidental overdose, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Adults and children 6 years of age and older: At the onset of symptoms, dissolve 2 tablets in the mouth every hour until symptoms are relieved. If necessary, dissolve 2 tablets in the mouth 15 minutes before meals. Children under 6 years of age: Ask a doctor.
SPL UNCLASSIFIED SECTION
do not use if glued carton and flaps are open or if the blister seal is broken.
store below 86°F (30° C)
Plant-Powered Relief
No Known Drug Interactions
60 Meltaway Tablets
*CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE, NOT ACCEPTED MEDICAL EVIDENCE. NOT FDA EVALUATED.
**C, K, CK, and X are homeopathic dilutions: see BoironUSA.com/info for details.
INACTIVE INGREDIENT SECTION
croscarmellose sodium, lactose, magnesium stearate.
OTC - QUESTIONS SECTION
Questions or comments?
BoironUSA.com
Info@Boiron.com
1-800-BOIRON-1
(1-800-264-7661)
Distributed by Boiron, Inc.
Newtown Square, PA 19073
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0220-9134-04 | 2023-01-31 | C162847 | 48780-1 | f386c649-a5d8-0266-e053-dadaa90a7c1a | Gasalia |
| 0220-9134-04 | 2023-01-30 | C162847 | 48780-1 | f386c649-a5d8-0266-e053-dadaa90a7c1a | Gasalia |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0220-9134-04 | Gasalia | 60 in 1 BLISTER PACK | TABLET | 60 | 8 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ACTIVATED CHARCOAL | ACTIVE INGREDIENT | 2P3VWU3H10 | 3 | |
| DAIKON | ACTIVE INGREDIENT | 86R5J6D01D | 3 | |
| LYCOPODIUM CLAVATUM SPORE | ACTIVE INGREDIENT | C88X29Y479 | 3 | |
| NUTMEG | ACTIVE INGREDIENT | AEE24M3MQ9 | 3 | |
| ACTIVATED CHARCOAL | ACTIVE MOIETY | 2P3VWU3H10 | 3 | |
| DAIKON | ACTIVE MOIETY | 86R5J6D01D | 3 | |
| LYCOPODIUM CLAVATUM SPORE | ACTIVE MOIETY | C88X29Y479 | 3 | |
| NUTMEG | ACTIVE MOIETY | AEE24M3MQ9 | 3 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | 3 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 3 |
Products#
Every source-derived product name is available through these pages.
- Gasalia
- ACTIVATED CHARCOAL, LYCOPODIUM CLAVATUM SPORE, NUTMEG, DAIKON
- CROSCARMELLOSE SODIUM
- LACTOSE
- MAGNESIUM STEARATE
- ACTIVATED CHARCOAL
- LYCOPODIUM CLAVATUM SPORE
- NUTMEG
- DAIKON
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0220-9134 | 0220-9134-04 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| LACTOSE | J2B2A4N98G | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| ACTIVATED CHARCOAL | 2P3VWU3H10 | ACTIB |
| LYCOPODIUM CLAVATUM SPORE | C88X29Y479 | ACTIB |
| NUTMEG | AEE24M3MQ9 | ACTIB |
| DAIKON | 86R5J6D01D | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gasalia | ACTIVATED CHARCOAL, LYCOPODIUM CLAVATUM SPORE, NUTMEG, DAIKON | Laboratoires Boiron | 3f93dfdc-8edb-4e4b-a571-4cd202e02113 | 2023-05-10 | 0220-9134-04 0220-9134 00220913404 fb5cf5e0-86d4-3f5a-e053-6294a90a2d38 3f93dfdc-8edb-4e4b-a571-4cd202e02113 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.




